The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 30, 2011
Filed:
Jul. 28, 2006
Kenneth Alan Simmen, Tervuren, BE;
Herman Augustinus DE Kock, Arendonk, BE;
Pierre Jean-marie Bernard Raboisson, Sterrebeek, BE;
Mats Stefan Lindström, Huddinge, SE;
Pia Cecilia Kahnberg, Huddinge, SE;
Dmitry Antonov, Huddinge, SE;
Karl Magnus Nilsson, Huddinge, SE;
Bengt Bertil Samuelsson, Huddinge, SE;
Åsa Annica Kristina Rosenquist, Huddinge, SE;
Kenneth Alan Simmen, Tervuren, BE;
Herman Augustinus De Kock, Arendonk, BE;
Pierre Jean-Marie Bernard Raboisson, Sterrebeek, BE;
Mats Stefan Lindström, Huddinge, SE;
Pia Cecilia Kahnberg, Huddinge, SE;
Dmitry Antonov, Huddinge, SE;
Karl Magnus Nilsson, Huddinge, SE;
Bengt Bertil Samuelsson, Huddinge, SE;
Åsa Annica Kristina Rosenquist, Huddinge, SE;
Tibotec Pharmaceuticals Ltd., , IE;
Medivir AB, , SE;
Abstract
Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; Ris hydrogen or Calkyl; Ris hydrogen or Calkyl; and n is 3, 4, 5, or 6;pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.